Home › Mesothelioma › Pennsylvania › Pittsburgh
Mesothelioma clinical trials in Pittsburgh, PA
6 studies for Mesothelioma are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
RecruitingPhase 2
- Allegheny Health Network (Data Collection Only), Pittsburgh
Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
RecruitingPhase 1
- AHN West Penn Hospital, Pittsburgh
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- Allegheny Health Network, Pittsburgh
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RecruitingPhase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
RecruitingPhase 1
- UPMC- Hillman Cancer Center, Pittsburgh
Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors
RecruitingPhase 1
- AHN West Penn Hospital, Pittsburgh
About Mesothelioma
Mesothelioma is a tumor of mesothelium, a tissue that lines lungs and other organs. Most people who get it have inhaled asbestos. Read the symptoms.
More about Mesothelioma on MedlinePlus
Mesothelioma trials in other cities
- Houston, TX15 studies
- New York City, NY10 studies
- Washington, DC9 studies
- Chicago, IL9 studies
- Nashville, TN8 studies
- Boston, MA8 studies
- Arlington, VA6 studies
- Philadelphia, PA6 studies
- Seattle, WA6 studies
- Los Angeles, CA6 studies
- Columbus, OH5 studies
- Rochester, MN5 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.